OpenURL Connection Search

Select item for more details and to access through your institution.

Safety and immunogenicity of 3 doses of BNT162b2 and CoronaVac in children and adults with inborn errors of immunity.
Published in:
Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.982155
By:
- Daniel Leung;
- Xiaofeng Mu;
- Duque, Jaime S. Rosa;
- Cheng, Samuel M. S.;
- Manni Wang;
- Wenyue Zhang;
- Yanmei Zhang;
- Tam, Issan Y. S.;
- Lee, Toby S. S.;
- Lam, Jennifer H. Y.;
- Sau Man Chan;
- Cheuk Hei Cheang;
- Yuet Chung;
- Wong, Howard H. W.;
- Lee, Amos M. T.;
- Wing Yan Li;
- Chaothai, Sara;
- Tsang, Leo C. H.;
- Chua, Gilbert T.;
- Kai-Ning Cheong
Publication type:
Article
An expanding rash.
Published in:
2014
By:
- Li, Margaret Wing Yan;
- Britton, Philip Neil
Publication type:
Other
Type 2 diabetes mellitus, blood cholesterol, triglyceride and colorectal cancer risk in Lynch syndrome.
Published in:
2019
By:
- Dashti, S. Ghazaleh;
- Li, Wing Yan;
- Buchanan, Daniel D.;
- Clendenning, Mark;
- Rosty, Christophe;
- Winship, Ingrid M.;
- Macrae, Finlay A.;
- Giles, Graham G.;
- Hardikar, Sheetal;
- Hua, Xinwei;
- Thibodeau, Stephen N.;
- Figueiredo, Jane C.;
- Casey, Graham;
- Haile, Robert W.;
- Gallinger, Steven;
- Le Marchand, Loïc;
- Newcomb, Polly A.;
- Potter, John D.;
- Lindor, Noralane M.;
- Hopper, John L.
Publication type:
journal article
Superior antibody and membrane protein-specific T-cell responses to CoronaVac by intradermal versus intramuscular routes in adolescents.
Published in:
World Journal of Pediatrics, 2024, v. 20, n. 4, p. 353, doi. 10.1007/s12519-023-00764-0
By:
- Rosa Duque, Jaime S.;
- Cheng, Samuel M. S.;
- Cohen, Carolyn A.;
- Leung, Daniel;
- Wang, Xiwei;
- Mu, Xiaofeng;
- Chung, Yuet;
- Lau, Tsun Ming;
- Wang, Manni;
- Zhang, Wenyue;
- Zhang, Yanmei;
- Wong, Howard H. W.;
- Tsang, Leo C. H.;
- Chaothai, Sara;
- Kwan, Tsz Chun;
- Li, John K. C.;
- Chan, Karl C. K.;
- Luk, Leo L. H.;
- Ho, Jenson C. H.;
- Li, Wing Yan
Publication type:
Article
Antibody and T cell responses against wild-type and Omicron SARS-CoV-2 after third-dose BNT162b2 in adolescents.
Published in:
Signal Transduction & Targeted Therapy, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41392-022-01282-7
By:
- Mu, Xiaofeng;
- Cohen, Carolyn A.;
- Leung, Daniel;
- Rosa Duque, Jaime S.;
- Cheng, Samuel M. S.;
- Chung, Yuet;
- Wong, Howard H. W.;
- Lee, Amos M. T.;
- Li, Wing Yan;
- Tam, Issan Y. S.;
- Lam, Jennifer H. Y.;
- Lee, Derek H. L.;
- Chan, Sau Man;
- Tsang, Leo C. H.;
- Chan, Karl C. K.;
- Li, John K. C.;
- Luk, Leo L. H.;
- Chaothai, Sara;
- Kwan, Kelvin K. H.;
- Chu, Nym Coco
Publication type:
Article

Found: 5

Safety and immunogenicity of 3 doses of BNT162b2 and CoronaVac in children and adults with inborn errors of immunity.

An expanding rash.

Type 2 diabetes mellitus, blood cholesterol, triglyceride and colorectal cancer risk in Lynch syndrome.

Superior antibody and membrane protein-specific T-cell responses to CoronaVac by intradermal versus intramuscular routes in adolescents.

Antibody and T cell responses against wild-type and Omicron SARS-CoV-2 after third-dose BNT162b2 in adolescents.